Generic Name and Formulations:
Sodium hyaluronate 5000 23mg/mL; viscoelastic soln for intraocular use.
Indications for HEALON5:
Inject through a fine cannula into the eye. Amount varies depending on surgery, repeated inj may be required. One syringe of 0.6mL is usually sufficient in anterior segment surgery.
Single use only; reuse may cause inflammatory reaction. Glaucoma; consider prophylactic pressure-lowering treatment. Complete removal of soln necessary to avoid intraocular pressure peaks post-op.
Ophthalmic viscosurgical device.
Incompatibility, resulting in opalescence, between sodium hyaluronate and solutions containing quaternary ammonium ions (eg, detergents, benzalkonium chloride).
Transient rise in intraocular pressure, myopic shift (if product not completely removed).
Clinical Pain Advisor Articles
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Opioids: Clinician Concern and Prescribing Practices
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Ensuring Safety During Long-Term Opioid Therapy
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Prescription Digital Therapeutic Approved for Opioid Use Disorder
- Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
- CDC: 8.8% of Individuals in the United States Uninsured in First Half of 2018
- Patient Experiences Shed Light on Diagnostic Errors
- Topical Migraine Trigger Point Treatment as Effective as Injection
- Wikipedia in Medical Education: An Educator's Guide to Crowdsourcing